Worth up to 12.25 credits!
Available Credits: ACPE-P/T, AMA, ANCC, APA, ASWB, CCMC, CDR and Attendance
Start Date: May 13, 2022
Expiration Date: May 13, 2024

Intended audience
These activities are designed to meet the educational needs of case managers, nurses, pharmacists, pharmacy technicians, physicians and other health care professionals (HCPs) who are interested in the care and management of oncology, solid organ and blood/marrow transplantation patient populations.

Activity Description
These activities consist of recordings from the "Essentials of Oncology, Solid Organ and Blood/Marrow Transplant Management for the Health Care Team" held March 14–15, 2022, in Scottsdale, Ariz.

Throughout these activities, faculty will discuss the keys to optimize the management/benefits of individuals with cancer and/or undergoing organ or blood/marrow transplant. Participants will hear about advances, trends and updates on relevant topics within these fields, such as the management of the medical, surgical, and psychosocial aspects of patient care along the transplant continuum; infectious disease and biomedical therapy updates; and changes to the national policy on organ allocation. Participants will learn about the latest guidelines in and future applications of transplantation and cancer care, as well as discover current and emerging strategies to adapt standards and best practices to improve patient care and outcomes.

Learning Objectives
At the end of these educational activities, participants should be able to:

  • Discover recent advances and future applications in precision medicine.
  • Recognize the psychosocial complications of post-hematopoietic stem-cell transplantation (HSCT) and detail the screening methods for and management of these complications.
  • Describe the recent developments in gene-cell therapy, the treatment of acute myeloid leukemia (AML), and CAR T-cell therapy for cancers.
  • Appreciate how social determinants of health (SDOH) impact outcomes in cancer patients.
  • Discuss utilizing biomarkers and genomics to optimize immunosuppression and reduce complications.
  • Explain the role of COVID-19 vaccination pre- and posttransplant and discuss future implications for nonvaccinated patients in need of organ transplantation.
  • Explore continuous distribution as an organ-allocation framework.
  • Determine the challenges and barriers surrounding liver transplant for acute-on-chronic liver failure (ACLF), factors that determine eligibility for transplant, and health -outcome predictors.
  • Analyze the recent trends in normothermic regional perfusion, multiorgan transplantation, and pancreatic transplantation.
  • Identify how geriatric and fragility assessments influence treatment selection.

Click on the activity title for more information or to view.

A Closer Look at Novel Treatment Therapies for Acute Myeloid Leukemia
Joseph Alvarnas, MD
Vice President, Government Affairs
Chief Clinical Advisor, AccessHope
Professor, Department of Hematology and Hematopoietic Cell Transplant
City of Hope
Duarte, CA
.75 credit

Emerging Applications of CAR T-cell Therapy in Cancer
Veronika Bachanova, MD, PhD
Professor of Medicine
Section Head Hematologic Malignancy
Division of Hematology, Oncology and Transplantation
University of Minnesota
Minneapolis, MN
1.00 credit

Islet Cell and Simultaneous Pancreas-Kidney Transplant
Daniel Borja-Cacho, MD
Assistant Professor of Surgery
Division of Organ Transplantation
Northwestern Medical Group
Chicago, IL
.75 credit

The Continuous Distribution Model: A New System for Organ Allocation
Maryjane Farr, MD, MSc, FACC, FAST
Section Chief, Heart Failure, MCS and Heart Transplantation
Jackie and Charles Solomon Distinguished Chair in Clinical Excellence
Professor of Medicine
University of Texas Southwestern Medical Center
Dallas, TX
.75 credit

Posttransplant Diagnostics: Utilizing Biomarkers and Genomics to Optimize Immunosuppression and Reduce Complications 
John J. Friedewald, MD
Professor of Medicine and Surgery
Medical Director of Kidney and Pancreas Transplantation
Northwestern Medical Group
Chicago, IL
1.00 credit

Advances in Gene Therapy for Sickle Cell Disease and Thalassemia
Stephan A. Grupp, MD, PhD
Section Chief, Cellular Therapy and Transplant Section
Director, Cancer Immunotherapy Program
Medical Director, Cell and Gene Therapy Laboratory
Children's Hospital of Philadelphia
Philadelphia, PA
.75 credit

Challenges and Considerations in Multi-organ Transplantation 
Valluvan Jeevanandam, MD
Cynthia Chow Professor of Surgery
Chief, Section of Cardiac Surgery
Director, Heart and Vascular Center
University of Chicago Medicine
Chicago, IL
.75 credit

Psychosocial Considerations in Post-Hematopoietic Stem Cell Transplantation
Nandita Khera, MD, MPH
Associate Professor of Medicine
Mayo Clinic, Phoenix
Phoenix, AZ
.75 credit

Selecting Appropriate Treatments Based on Geriatric and Fragility Assessments
Jennifer C. Lai, MD, MBA
FDA GI Drugs Advisory Committee Member
Transplant Hepatologist
Associate Professor of Medicine
Director, Clinical Liver Research
University of California San Francisco
San Francisco, CA
.75 credit

Precision Medicine: Expanding Opportunities
Jason D. Merker, MD, PhD
Associate Professor, Pathology and Laboratory Medicine
Associate Professor, Genetics
Director, Cancer Molecular Pathology
Co-Director, Translational Genomics Laboratory
Lineberger Comprehensive Cancer Center;
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, NC
1.00 credit

Updates on Xenotransplantation and the Artificial Kidney
Robert Montgomery, MD, PhD
Chair, Department of Surgery
NYU Langone Transplant Institute
New York, NY
1.00 credit

Normothermic Regional Perfusion
Victor Pretorius, MBChB
Cardiothoracic Surgeon
Surgical Director, Cardiac Transplant and Mechanical Circulatory Support
UC San Diego Health
San Diego, CA
.75 credit

Implications for Transplantation in Acute-on-Chronic Liver Failure: Determining a Course of Action
Vinay Sundaram, MD, MSc
Director, Hepatology Outcomes Research
Assistant Medical Director, Liver Transplantation
Cedars-Sinai Medical Center
Los Angeles, CA
.75 credit

Social Determinants of Health in Cancer Care
Karen M. Winkfield, MD, PhD
Professor of Radiation Oncology
Vanderbilt University Medical Center;
Ingram Professor of Cancer Research
Vanderbilt Ingram Cancer Center;
Professor of Medicine
Meharry Medical College;
Executive Director
Meharry-Vanderbilt Alliance
Nashville, TN
.75 credit

COVID-19 Vaccination Considerations Along the Transplant Continuum 
Cameron R. Wolfe, MBBS
Associate Professor of Medicine
Associate of the Duke Initiative for Science & Society
Duke University School of Medicine
Durham, NC
.75 credit

Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Participants will receive a certificate upon successful completion of the activity, which includes the following:

  • Completing the entire activity
  • Completing the Activity Evaluation and Application for Certificate of Credit forms

You must be logged into your account to participate in this activity. Get started by clicking the down arrow and then "Start" under “Webcast”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”

Provided By
These activities are provided by OptumHealth Education.

Commercial Support
There was no commercial support provided for these activities.

Hardware/Software Requirements
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.